{"id":"https://openalex.org/W2598040025","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e14569","title":"A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer.","display_name":"A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer.","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2598040025","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e14569","mag":"2598040025"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.e14569","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e14569","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e14569","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101997154","display_name":"Zheng Wu","orcid":"https://orcid.org/0000-0002-2441-0229","observed_orcids":["https://orcid.org/0000-0002-2441-0229"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zheng Wu","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061373605","display_name":"John Lindsay Marshall","orcid":"https://orcid.org/0000-0002-3449-2344","observed_orcids":["https://orcid.org/0000-0002-3449-2344"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Marshall","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104103465","display_name":"Jimmy J. Hwang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jimmy J. Hwang","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021453899","display_name":"Michael Jon Pishvaian","orcid":"https://orcid.org/0000-0002-1165-9041","observed_orcids":["https://orcid.org/0000-0002-1165-9041"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Pishvaian","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076845153","display_name":"Anton Wellstein","orcid":"https://orcid.org/0000-0002-0570-4950","observed_orcids":["https://orcid.org/0000-0002-0570-4950"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anton Wellstein","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045107557","display_name":"Louis M. Weiner","orcid":"https://orcid.org/0000-0001-5192-0710","observed_orcids":["https://orcid.org/0000-0001-5192-0710"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis M. Weiner","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045096676","display_name":"Aiwu Ruth He","orcid":"https://orcid.org/0000-0002-2104-0816","observed_orcids":["https://orcid.org/0000-0002-2104-0816"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aiwu Ruth He","raw_affiliation_strings":["Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"e14569","last_page":"e14569"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9330000281333923},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7910000085830688},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8159999847412109},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/gemcitabine-refractory-pancreatic-cancer","display_name":"gemcitabine-refractory pancreatic cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6489999890327454},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7559999823570251},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9570000171661377},{"id":"https://openalex.org/keywords/microrna-biomarkers","display_name":"microRNA biomarkers","score":0.8119999766349792},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5989999771118164},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.6000000238418579},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.41600000858306885},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9053840637207031},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.8868339657783508},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.802493691444397},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7444742321968079},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6904700398445129},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6750342845916748},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6071043610572815},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5688801407814026},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5584264397621155},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.497649222612381},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49537861347198486},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.48754259943962097},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.43645668029785156},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4305158257484436},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41557711362838745},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3640151023864746},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34032589197158813},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.24850106239318848},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19271555542945862},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.1235591471195221},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1102343499660492},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.10927170515060425}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.e14569","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e14569","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e14569","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586944527","https://openalex.org/W1848284733","https://openalex.org/W2561025749","https://openalex.org/W2266044370","https://openalex.org/W2591073060","https://openalex.org/W2253313208","https://openalex.org/W2228742503","https://openalex.org/W2068345698","https://openalex.org/W2224004331","https://openalex.org/W1989245824"],"abstract_inverted_index":{"e14569":[0],"Background:":[1],"The":[2,161,224,235,307],"anti-EGFR":[3],"therapy":[4],"erlotinib":[5],"was":[6,164,230,238,246,285],"FDA":[7],"approved":[8],"for":[9,296,317],"the":[10,28,88,104],"treatment":[11,106,228],"of":[12,27,31,46,62,71,90,97,107,150,190,201,211,227,293,309,334,338],"patients":[13,186,192,203,213,259,266,318,325],"with":[14,54,113,119,303,319],"advanced":[15],"pancreas":[16],"cancer.":[17,110,323],"Human":[18],"epidermal":[19],"growth":[20,32],"factor":[21,33],"receptor":[22,34],"2":[23,159,198,200,265],"(HER-2),":[24],"a":[25,92,314],"member":[26],"ErbB":[29],"family":[30],"tyrosine":[35,94],"kinases":[36],"to":[37,86,299,328],"which":[38],"EGFR":[39,51,98],"belongs,":[40],"is":[41,313,341],"found":[42],"overexpressed":[43],"in":[44,67,103,257,264,272,280],"20%":[45],"pancreatic":[47,63,73,109,117,322],"cancers":[48],".":[49],"Targeting":[50],"and":[52,99,101,125,128,140,175,183,209,218,276,291,311],"HER-2":[53],"separate":[55],"specific":[56],"monoclonal":[57],"antibodies":[58],"showed":[59],"synergistic":[60],"inhibition":[61],"cancer":[64,74,118],"tumor":[65],"progression":[66,176,196,295],"mice":[68],"bearing":[69],"xenograft":[70],"human":[72],"cell":[75],"lines.":[76],"We":[77],"performed":[78,157],"an":[79],"open-label":[80],"single":[81],"arm":[82],"phase":[83],"II":[84],"study":[85],"evaluate":[87],"combination":[89,308],"lapatinib,":[91],"dual":[93],"kinase":[95],"inhibitor":[96],"HER-2,":[100],"capecitabine":[102,141,312],"second-line":[105],"metastatic":[108,321],"Methods:":[111],"Patients":[112,133],"metastatic,":[114],"unresectable,":[115],"gemcitabine-refractory":[116,320],"adequate":[120],"performance":[121],"status":[122],"(ECOG":[123],"0-2)":[124],"normal":[126],"hepatic":[127],"renal":[129],"function":[130],"were":[131,156,326],"eligible.":[132],"received":[134,187,219],"lapatinib":[135,310],"1,250":[136],"mg":[137],"PO":[138,144],"daily,":[139],"1,000":[142],"mg/m2":[143],"twice":[145],"daily":[146],"on":[147],"days":[148],"1-14":[149],"each":[151],"21-day":[152],"cycle.":[153],"Restaging":[154],"studies":[155],"every":[158],"cycles.":[160,223],"primary":[162],"endpoint":[163],"median":[165,225,236],"overall":[166],"survival":[167,178],"(OS).":[168],"Secondary":[169],"endpoints":[170],"included":[171],"response":[172],"rate":[173],"(RR)":[174],"free":[177],"(PFS).":[179],"Results:":[180],"Between":[181],"9-2009":[182],"8-2011,":[184],"17":[185,191,202,212],"treatment.":[188],"Six":[189],"(24%)":[193,214],"had":[194,215],"disease":[195,217,294],"after":[197,206],"cycles,":[199],"(12%)":[204],"progressed":[205],"4":[207,210],"cycles":[208,229,333],"stable":[216],"more":[220,332],"than":[221],"6":[222,330],"number":[226],"3":[231,254,258,262,269,278],"(range":[232],"1-22":[233],"cycles).":[234],"PFS":[237],"9":[239],"weeks":[240,248,290],"(95%":[241,249],"CI":[242,250],"7.1-18.9).":[243],"Median":[244],"OS":[245],"25":[247],"11":[251],"-34).":[252],"Grade":[253],"nausea,":[255],"vomiting":[256],"(17%),":[260],"grade":[261,268,277],"diarrhea":[263],"(12%),":[267],"limb":[270],"edema":[271],"1":[273,281],"patient":[274,282],"(6%),":[275],"fatigue":[279],"(6%).":[283],"Serum":[284],"collected":[286],"at":[287],"baseline,":[288],"three":[289],"time":[292],"microRNA":[297],"analysis":[298,337],"identify":[300],"biomarkers":[301],"correlated":[302],"clinical":[304],"outcome.":[305],"Conclusions:":[306],"tolerated":[315],"regimen":[316],"Some":[324],"able":[327],"receive":[329],"or":[331],"therapy.":[335],"Molecular":[336],"patients\u2019":[339],"biosamples":[340],"ongoing.":[342]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-04-07T00:00:00"}